Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - Anlotinib Dihydrochloride

Anlotinib Dihydrochloride

CAS No. 1360460-82-7

Anlotinib Dihydrochloride( Anlotinib (AL3818) dihydrochloride | AL3818 dihydrochloride )

Catalog No. M19393 CAS No. 1360460-82-7

Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Anlotinib Dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities.
  • Description
    Anlotinib also known as AL3818 is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration anlotininib targets multiple RTKs including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Anlotinib (AL3818) dihydrochloride | AL3818 dihydrochloride
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR2| VEGFR3|c-Kit
  • Research Area
    Cancer
  • Indication
    Non-small cell lung Cancer

Chemical Information

  • CAS Number
    1360460-82-7
  • Formula Weight
    480.36
  • Molecular Formula
    C23H24Cl2FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:87 mg/mL(181.1 mM)
  • SMILES
    Cc1cc2c([nH]1)ccc(c2F)Oc1c2cc(c(cc2ncc1)OCC1(CC1)N)OC.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yongkun Sun et al. Safety pharmacokinetics and antitumor properties of anlotinib an oral multi-target tyrosine kinase inhibitor in patients with advanced refractory solid tumors. Journal of Hematology & Oncology20169:105
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • SU 4981

    SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.

  • R1530

    R1530 is a multikinase inhibitor with antineoplastic and antiangiogenesis activities.

  • Nintedanib

    A potent triple angiokinase (VEGFR/PDGFR/FGFR) inhibitor with IC50 of 5/38/18/104/5 nM for VEGFR-2/FGFR-1/PDGFRα/VEGFR-1/VEGFR-3, respectively.

Sign In Join Free